Clinical Trials

6 enrolled

Stomach Neoplasms

NCT03382600 2024-06-11

KEYNOTE-659

100 enrolled 21 charts

Stomach Neoplasms

NCT04999332 2023-11-15

LOTS

58 enrolled

Stomach Neoplasms

NCT02191566 2022-12-08

SOHUG

8 enrolled

Stomach Neoplasms

NCT00429858 2020-09-18

Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic Cancer

21 enrolled 8 charts

Pancreatic Neoplasms

NCT02301481 2019-10-16

A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcinoma

71 enrolled

Stomach Neoplasms

NCT01283204 2019-01-29

Trial of 4-regimen (SP, FL/Tax, FL/Doc, FOLFOX) in Patients With Recurrent or Metastatic Gastric Cancer

180 enrolled

Recurrence, Stomach Neoplasms

NCT01815307 2018-05-16

Phase II Study of Gemcitabine Versus S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer

70 enrolled

Biliary Tract Neoplasms

NCT01430052 2017-11-21

Chemoradiotherapy With Gemcitabine/S-1 vs Gemcitabine/S-1 for Locally Advanced Pancreatic Cancer

110 enrolled

Pancreatic Neoplasms

NCT03316326 2017-10-20

S-1, Irinotecan, and Oxaliplatin in Locally-Advanced Pancreatic Cancer

35 enrolled

Pancreatic Ductal Adenocarcinoma

NCT01693419 2017-08-23

S-1, Gemcitabine and Erlotinib for Advanced Pancreatic Cancer

37 enrolled

Pancreatic Neoplasms

NCT01693432 2017-08-23

Docetaxel and S-1 for Advanced Esophageal Cancer

37 enrolled

Esophageal Neoplasms

NCT02527785 2017-08-23

Study of Oxaliplatin, Irinotecan, and S-1 in Gastric Cancer

44 enrolled

Stomach Neoplasms

NCT03137004 2017-05-08

Docetaxel and S-1 Combination Therapy as Second-line Treatment for Advanced Gastric Cancer

47 enrolled

Advanced Gastric Cancer

NCT02870153 2016-08-19

SOX Versus XELOX for Patients With Peritoneal Metastasis of Colorectal Cancer

60 enrolled

Colorectal Neoplasms

NCT01980810 2016-06-14

GC-A-003

36 enrolled

Stomach Neoplasms

NCT01679340 2015-05-19

A PhaseⅡ Study: SOX vs SP in Adjuvant Chemotherapy After D2 Surgery

160 enrolled

Stomach Neoplasms

NCT01269216 2015-01-28

A Study of Neoadjuvant Chemoradiotherapy With 5-FU/Leucovorin (FL) vs. TS-1/Irinotecan in Patients With Locally Advanced Rectal Cancer

136 enrolled

Rectal Neoplasms

NCT01531452 2014-12-04

The Efficacy of Oxaliplatin Plus S-1 for Treatment of Gastric Cancer

43 enrolled

Stomach Neoplasms

NCT02146703 2014-05-26

Gemcitabine and S-1 for Advanced Biliary Tract Cancer

38 enrolled

Biliary Tract Neoplasms

NCT01824004 2013-04-04

Postoperative Chemoradiotherapy With S-1 in Gastric Cancer

46 enrolled

Stomach Neoplasms

NCT00677144 2012-10-05

Oxaliplatin and S-1 (OS) Versus Oxaliplatin and Capecitabine (XELOX) for Advanced Colorectal Cancer

88 enrolled

Colorectal Neoplasms

NCT01608646 2012-05-31

Study of DPD for Predicting Efficacy and Safety to S-1 Plus Oxaliplatin in Gastrointestinal Cancer

200 enrolled

Gastrointestinal Neoplasms

NCT01533324 2012-02-15

S-1/LV One Week on and One Week Off Regimen in Advanced Hepatocellular Carcinoma (HCC)

32 enrolled

Carcinoma, Carcinoma, Hepatocellular, Liver Diseases

NCT00514163 2011-06-28

GEM vs GEM+TS-1 for Advanced Pancreatic Cancer

110 enrolled

Pancreatic Neoplasms

NCT01096745 2011-06-23

Randomized Trial of Gemcitabine/Cisplatin Versus S-1/Cisplatin in Advanced Biliary Cancer

78 enrolled

Bile Duct Neoplasms, Biliary Tract Neoplasms

NCT00512681 2009-09-18

TIROX2

44 enrolled

Neoplasm Metastasis, Stomach Neoplasms

NCT00961077 2009-08-18

Attenuated SOX as First-line Treatment in Elderly Patients With Relapsed or Metastatic Gastric Cancer

36 enrolled

Recurrence, Stomach Neoplasms

NCT00209651 2007-11-01

Phase II Study of Oral S-1 Plus Irinotecan (IRIS) in Patients With Advanced Colorectal Cancer

40 enrolled

Colorectal Neoplasms

NCT00436423 2007-11-01

A Phase Ⅱ Study of Gemcitabine Combination With TS-1 in Patient With Advanced or Recurred Pancreatic Cancer

38 enrolled